Hut 8 Corp. (NASDAQ:HUT) saw Wall Street analysts reiterate their bullish stance on the vertically integrated operator of ...
Denali Therapeutics shares reversed higher on Tuesday after the drugmaker's ALS treatment failed in a six-month study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback